Home : FDA Drug Database : Lupron : Jury Verdicts
Lupron - Jury Verdicts
-
Facts: Plaintiff's decedent was being treated by defendants gynecologist and internist with Lupron for endometriomas and endometriosis (cysts in the uterine wall.) With an estrogen surge, the endometrioma grew seven-fold, compressing pelvic veins and resulting in deep vein thrombosis (DVT). Decedent was unable to ambulate without assistance for two months at which time she was referred to...
- from The DC Verdict Reporter (97399) Login for Lupron Verdict -
This medical malpractice action arose out of the death of a female plaintiff from deep vein thrombosis allegedly stemming from a pelvic mass associated with the patient's endometriosis condition. The plaintiff contended that the defendant gynecologist failed to properly manage and treat the plaintiff's endometriosis, allowing progression of the condition to the point where the ...
- from The National Jury Verdict Review and Analysis (6880) Login for Lupron Verdict -
This medical malpractice action was brought by the female plaintiff, age 19 when she was admitted by the defendant family practitioner to the hospital for evaluation and treatment of her pelvic pain. The plaintiff contended that the defendant family practitioner failed to properly rule out bowel perforation following a scoping procedure performed in late April, 1998. The pla...
- from The National Jury Verdict Review and Analysis (7134) Login for Lupron Verdict -
This was a negligence/consumer fraud action in which the plaintiffs consisting of classes comprised of patients, health care plans and insurers sought damages from the defendants due to an alleged scheme by the defendants to inflate the retail price of the drug Lupron. This matter was certified as a class action by the court.
In this case, the plaintiffs were consumers and third...
- from The New England Jury Verdict Review and Analysis (42941) Login for Lupron Verdict -
This was a negligence/consumer fraud action in which the plaintiffs consisting of classes comprised of patients, health care plans and insurers sought damages from the defendants due to an alleged scheme by the defendants to inflate the retail price of the drug Lupron. This matter was certified as a class action by the court.
In this case, the plaintiffs were consumers and third...
- from The National Jury Verdict Review and Analysis (43543) Login for Lupron Verdict
Want to contact a Lupron lawyer in Washington, DC? ...Get a free case evaluation from one of our Lupron lawyers in Washington, DC now.
